Ronawk

Olathe, United States

Ronawk develops a T-Block technology producing patient-specific biologics to treat diseases, cancer, organ injuries, and burns.

$6.5M raised

May 2023

Series A

Top Investors

MassChallengeAccelerate Venture Partners

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Ronawk raised?

Ronawk has raised $6.5M in total funding. The most recent round was Series A. The last funding was announced in May 2023.

Who are Ronawk's investors?

Ronawk's investors include MassChallenge, Accelerate Venture Partners.

Where is Ronawk headquartered?

Ronawk is headquartered in Olathe, United States.

What does Ronawk do?

Ronawk develops a T-Block technology producing patient-specific biologics to treat diseases, cancer, organ injuries, and burns.

What stage is Ronawk at?

Ronawk is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 9, 2023.

MLA

"Ronawk — Funding & Investors." VCBacked, May 9, 2023, https://www.vcbacked.co/company/ronawk. Accessed June 4, 2026.

APA

VCBacked. (2023). Ronawk — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/ronawk

Wikipedia (cite web)

{{cite web |title=Ronawk — Funding & Investors |url=https://www.vcbacked.co/company/ronawk |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 9, 2023.